Results 151 to 160 of about 13,054 (213)

FAME-CRISPR improves CRISPR-Cas9 genome editing via HDAC inhibition and engineered virus-like particle delivery. [PDF]

Cell Rep Methods
Djamshidi M, Hill A, Heshmatzad K, Langley J, Krowicki H, Ali M, Yang Y, Tanida R, Abdul-Careem MF, Billon P, Riabowol K.   +10 more
europepmc   +1 more source

Microbial short chain fatty acids: Effective histone deacetylase inhibitors in immune regulation (Review). [PDF]

Int J Mol Med
Wang J, Zhao Q, Zhang S, Liu J, Fan X, Han B, Hou Y, Ai X.   +7 more
europepmc   +1 more source

Metabolite mimicry identifies butyrate analogs with select protective functions in the intestinal mucosa. [PDF]

Proc Natl Acad Sci U S A
Ornelas A, Countess JA, Kim JY, Cohen RH, Gomez BD, Roer RL, Minhajuddin F, Yenugudhati Vijaya Sai K, Zhou L, Dunn JLM, Chandler C, Reigan P, Cartwright IM, Hall CHT, Bhagavatula G, Onyiah JC, Dowdell AS, Colgan SP.   +17 more
europepmc   +1 more source

Targeting histone deacetylation, cell cycle regulators and heat shock proteins as novel therapeutic strategies for penile cancers. [PDF]

NPJ Precis Oncol
Marson L, Skowron MA, Pongratanakul P, Kotthoff M, Poschmann G, Bohnenberger H, Stephan A, Watolla MM, Mukinovic E, Stühler K, Kurz T, Ayoubian H, Linxweiler J, Junker K, Nettersheim D.   +14 more
europepmc   +1 more source

Inhibition of Histone Deacetylases Induces Cancer Cell Apoptosis Through the PERK Pathway of ER Stress Response. [PDF]

J Cell Mol Med
Wang X, Yang C, Yang Y, Xu F, Yuan D, Gu Y.   +5 more
europepmc   +1 more source

Interplay Between Poly(ADP-ribosyl)ation and Specific Inner Cellular Events That Suggest Combination Strategies for Overcoming PARP Inhibitor Resistance. [PDF]

Pharmaceutics
Xu L, Kong X, Zhang B, Ma H, Li X, Deng Y, Liu W, Ren W, Tang X, Zhang D.   +9 more
europepmc   +1 more source

Zinc Affinity of Benzamide-Based Histone Deacetylase Inhibitors: A DFT Study. [PDF]

Molecules
Toshev N, Velichkov K, Uzunova Y, Cheshmedzhieva D, Dudev T.   +4 more
europepmc   +1 more source

Modulation of Tau Protein Neurotoxic Hallmarks by Novel σ₁R Agonists/HDAC Inhibitor Dual-Acting Compounds. [PDF]

ChemMedChem
Fallica AN, Barbaraci C, Ruiz-Cantero MC, Scarlatti A, Coco A, Giordano G, La Mantia A, Prezzavento O, Di Stefano A, Cacciatore I, Siano G, Cattaneo A, Pasquinucci L, Cobos EJ, Di Primio C, Amata E, Marrazzo A.   +16 more
europepmc   +1 more source

Reversing Bladder Cancer Chemo-resistance through Blocking Cell Senescence by a Combination Therapy. [PDF]

Theranostics
He Y, Fang Z, Zhang J, Wei Q, Li Y, Duan Z, Xu G, Lin T, Xiong Q, Gong Q, Tan P, Luo K.   +11 more
europepmc   +1 more source

Non-enzymatic acetylation of lysine residues affects the stability of Rubisco activase. [PDF]

aBIOTECH
Yang L, Li Y, Hong H, Luo C, Gao X, Shu Z, Mi HL, Chen GY, Qu M.   +8 more
europepmc   +1 more source